This new device will enable researchers to achieve a more complete understanding of blood glucose levels and ultimately, the development of better drugs, devices, and therapies for people.
ST. PAUL, MN (PRWEB) June 10, 2016
Data Sciences International (DSI), DSI announced the introduction of continuous glucose telemetry implants for use in mice. The revolutionary glucose telemetry technology gives scientists the ability to collect continuous, real-time measurements of blood glucose in laboratory rodents.
The continuous glucose telemetry implant includes a sensor, placed directly into the bloodstream to detect instantaneous changes in blood glucose. The implant also measures body temperature and activity. Data is wirelessly communicated to DSI’s PhysioTel ™ hardware and digitally stored in DSI’s Ponemah software. Continuous glucose telemetry reduces animal stress and measurement variability commonly associated with the use of glucose test strips or other more invasive techniques. Early studies suggest that because of the precision of these chronic, continuous measurements, the number of mice used per study can be significantly reduced.
“Since the introduction of our glucose implant for rats, DSI has received overwhelmingly positive feedback from the scientific community," said COO Kristen Knox. "We are committed to advancing science and because a high percentage of diabetic research is done using transgenic mice, we invested to develop a product ideal for the mouse model." Knox continued, “This new device will enable researchers to achieve a more complete understanding of blood glucose levels and ultimately, the development of better drugs, devices, and therapies for people.”
DSI is a pioneering biomedical company focused on preclinical systems for physiology and pharmacology research. The recognized global leader in physiologic monitoring, DSI offers telemetry, instrumentation, software and services that help advance science. DSI serves many industries including: Pharmaceuticals, Academia, Contract Research Organizations, Biological and Chemical Defense, the Medical Device Industry, Government, and Biotechnology companies. Solutions are tailored specifically to meet the unique research needs of its customers.
Visit http://www.datasci.com for more about the company.